Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Epygenix Therapeutics Inc.
Sponsor

Epygenix Therapeutics Inc.

United States 630 West Germantown Pike Suite 215, 19462-1069, United States

About the sponsor

Epygenix Therapeutics Inc. focuses on clinical research in epileptic encephalopathies, with activity centered on Dravet syndrome and Lennox-Gastaut syndrome. These conditions reflect a therapeutic interest in severe, treatment-resistant seizure disorders affecting children and adults.

  • Dravet syndrome
  • Lennox-Gastaut syndrome
  • Seizure control
  • Rare pediatric neurology

The sponsor’s clinical program is aligned with neurological disease management in populations with complex and persistent seizure burden.

About Specializations

Epygenix Therapeutics Inc. runs clinical trials in conditions such as Lennox-Gastaut syndrome, Severe myoclonic epilepsy of infancy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Lennox-Gastaut syndrome

Recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years
  • Substances:Clemizole Hydrochloride
  • Sponsor:Epygenix Therapeutics Inc.

Severe myoclonic epilepsy of infancy

Recruiting
Investigational
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Clemizole Hydrochloride
  • Sponsor:Epygenix Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.